A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Intra-IMMUSG Pte Ltd
Intra-IMMUSG Pte Ltd
AstraZeneca
Amgen
Zymeworks BC Inc.
Seqker Biosciences, Inc.
Duke University
University of Florida
National Institutes of Health Clinical Center (CC)
University Hospital, Lille
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
M.D. Anderson Cancer Center
Hoffmann-La Roche
Bristol-Myers Squibb
Inova Health Care Services
Fenerbahce University
Istituto Giannina Gaslini
Case Comprehensive Cancer Center
NY Health d/b/a New York Cancer and Blood Specialists
Stiftelsen Stockholms Sjukhem
National Institutes of Health Clinical Center (CC)
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Zhejiang Cancer Hospital
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
European Organisation for Research and Treatment of Cancer - EORTC
University of Texas Southwestern Medical Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Tagworks Pharmaceuticals BV
Institut de Cancérologie de Lorraine
Celtic Biotech Ltd
M.D. Anderson Cancer Center
Bayer
EMD Serono
AbbVie
The Clatterbridge Cancer Centre NHS Foundation Trust
University Health Network, Toronto
Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd.
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Institut Claudius Regaud